Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Free Cash Flow (2019 - 2025)

Historic Free Cash Flow for Cresco Labs (CRLBF) over the last 7 years, with Q3 2025 value amounting to $13.3 million.

  • Cresco Labs' Free Cash Flow fell 7592.86% to $13.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.0 million, marking a year-over-year increase of 15961.19%. This contributed to the annual value of $113.0 million for FY2024, which is 345419.94% up from last year.
  • Cresco Labs' Free Cash Flow amounted to $13.3 million in Q3 2025, which was down 7592.86% from $13.1 million recorded in Q2 2025.
  • In the past 5 years, Cresco Labs' Free Cash Flow registered a high of $72.5 million during Q2 2021, and its lowest value of -$149.3 million during Q4 2022.
  • Over the past 5 years, Cresco Labs' median Free Cash Flow value was $13.7 million (recorded in 2022), while the average stood at $1.4 million.
  • As far as peak fluctuations go, Cresco Labs' Free Cash Flow surged by 54830.19% in 2021, and later plummeted by 8159.25% in 2024.
  • Quarter analysis of 5 years shows Cresco Labs' Free Cash Flow stood at -$132.8 million in 2021, then decreased by 12.45% to -$149.3 million in 2022, then grew by 26.82% to -$109.3 million in 2023, then surged by 94.24% to -$6.3 million in 2024, then skyrocketed by 312.01% to $13.3 million in 2025.
  • Its Free Cash Flow was $13.3 million in Q3 2025, compared to $13.1 million in Q2 2025 and $5.8 million in Q1 2025.